SEC Form 4 · accession 0000939767-17-000030
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Morrissey
Officer — President and CEO · Director
Period of report
Mar 3, 2017
Accepted (ET)
Mar 7, 2017 · 7:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 3, 2017 | M | 100,000 | $9.91 | A | 160,000 | D | |
| Common StockF2 | Mar 3, 2017 | S | 100,000 | $22.83 | D | 60,000 | D | |
| Common Stock | Mar 6, 2017 | M | 100,000 | $9.91 | A | 160,000 | D | |
| Common StockF3 | Mar 6, 2017 | S | 100,000 | $22.61 | D | 60,000 | D | |
| Common StockF4 | holding | — | — | — | 172,698 | I | By Trust | |
| Common StockF5 | holding | — | — | — | 16,825 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F6 | $9.91 | Mar 3, 2017 | M | 100,000 | D | Dec 6, 2008 | Dec 5, 2017 | Common Stock | 100,000 | 100,000 | D |
| Option (right to buy)F6 | $9.91 | Mar 6, 2017 | M | 100,000 | D | Dec 6, 2008 | Dec 5, 2017 | Common Stock | 100,000 | 0 | D |
Explanation of responses
- F1Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.80 to $22.94. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.50 to $22.69. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- F4Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
- F5Represents 16,825 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 6, 2017.
- F6The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2011.